Congress to examine drug price hikes

Jan 29, 2019
Prescription drug prices have been rising over the past few years.
jorgeantonio/iStock/Getty Images Plus

Big Pharma is betting big on cancer drugs

Jan 3, 2019
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer…
pxhere

Why some people are worried about drug patent protections in the new NAFTA

Oct 2, 2018
The trade agreement reached over the weekend between the U.S., Canada and Mexico includes longer intellectual property protection periods for the expensive class of drugs known as biologics.
LARS HAGBERG/AFP/Getty Images

Generic Viagra floods the market. Here’s how Pfizer is reacting

Jul 13, 2018
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
Christopher Furlong/Getty Images

The FDA approves the first drug derived from cannabis

Jun 28, 2018
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
An assistant studies cannabis leaves in the Maripharma Laboratory in Rotterdam, Netherlands, in 2002.
Michel Porro/Getty Images

Senate to scrutinize hospitals on low-income patient profits and spending

Jun 19, 2018
This morning, a Senate committee checks in to see how the cuts to the so-called 340b program, which allows hospitals to buy drugs at a discount, are impacting hospitals and patients. Critics say there’s little evidence that hospitals used the savings…

FDA website to post names of drug makers blocking development of cheaper generics

May 17, 2018
The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb’s larger crackdown to, as…

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.